Cargando…

Characterization of aging cancer-associated fibroblasts draws implications in prognosis and immunotherapy response in low-grade gliomas

Background: Due to the highly variable prognosis of low-grade gliomas (LGGs), it is important to find robust biomarkers for predicting clinical outcomes. Aging cancer-associated fibroblasts (CAFs) within the senescent stroma of a tumor microenvironment (TME) have been recently reported to play a key...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Zijian, Wei, Jinhong, Kuang, Lijun, Zhang, Ke, Liu, Yini, He, Zhongming, Li, Luo, Lu, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449154/ https://www.ncbi.nlm.nih.gov/pubmed/36092895 http://dx.doi.org/10.3389/fgene.2022.897083

Ejemplares similares

Comprehensive Characterization of Pyroptosis Patterns with Implications in Prognosis and Immunotherapy in Low-Grade Gliomas
por: Zhou, Zijian, et al.
Publicado: (2022)

Characterization of aging tumor microenvironment with drawing implications in predicting the prognosis and immunotherapy response in low-grade gliomas
por: Zhou, Zijian, et al.
Publicado: (2022)

Single cell RNA sequencing reveals differentiation related genes with drawing implications in predicting prognosis and immunotherapy response in gliomas
por: Zhou, Zijian, et al.
Publicado: (2022)

Comprehensive Characterization of a Novel E3-Related Gene Signature With Implications in Prognosis and Immunotherapy of Low-Grade Gliomas
por: Tan, Shichuan, et al.
Publicado: (2022)

Characterization of the Ferroptosis-Related Genes for Prognosis and Immune Infiltration in Low-Grade Glioma
por: Yan, Xiuwei, et al.
Publicado: (2022)

Machine learning identification of cuproptosis and necroptosis-associated molecular subtypes to aid in prognosis assessment and immunotherapy response prediction in low-grade glioma
por: Miao, Ye, et al.
Publicado: (2022)

An immune and epithelial–mesenchymal transition-related risk model and immunotherapy strategy for grade II and III gliomas
por: Luo, Wei, et al.
Publicado: (2023)

High Expression of PLAGL2 is Associated With Poor Prognosis in High-Grade Glioma
por: Wang, Gang, et al.
Publicado: (2022)

Establishing a glutamine metabolism-based model for predicting the prognosis of low-grade glioma
por: Zhang, Mingshi, et al.
Publicado: (2022)

Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma
por: Zhang, Mingwei, et al.
Publicado: (2020)

Prognosis and immune response of a cuproptosis-related lncRNA signature in low grade glioma
por: Xu, Yifan, et al.
Publicado: (2022)

Genome Instability-Associated Long Non-Coding RNAs Reveal Biomarkers for Glioma Immunotherapy and Prognosis
por: Wang, Xinzhuang, et al.
Publicado: (2022)

Identification of a Tumor Microenvironment-Related Eight-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas
por: Su, Jun, et al.
Publicado: (2019)

A Novel Inflammatory lncRNAs Prognostic Signature for Predicting the Prognosis of Low-Grade Glioma Patients
por: Xiang, Zijin, et al.
Publicado: (2021)

High expression of ZFP36L2 correlates with the prognosis and immune infiltration in lower-grade glioma
por: Zhou, Min, et al.
Publicado: (2022)

Ferroptosis regulators related scoring system by Gaussian finite mixture model to predict prognosis and immunotherapy efficacy in nasopharyngeal carcinoma
por: Liu, Zijian, et al.
Publicado: (2022)

The integrative analysis based on super-enhancer related genes for predicting different subtypes and prognosis of patient with lower-grade glioma
por: Hu, Yungang, et al.
Publicado: (2023)

Comprehensive pan-cancer analysis of N7-methylguanosine regulators: Expression features and potential implications in prognosis and immunotherapy
por: Wei, Wei, et al.
Publicado: (2022)

Construction of cuproptosis-related gene signature to predict the prognosis and immunotherapy efficacy of patients with bladder cancer through bioinformatics analysis and experimental validation
por: Liu, Zijian, et al.
Publicado: (2022)

CCR5 as a Prognostic Factor in Lower-Grade Glioma is Involved in the Remodeling of the Tumor Microenvironment
por: Wang, Fang, et al.
Publicado: (2022)

Comprehensive characterization of TNFSF14/LIGHT with implications in prognosis and immunotherapy of human gliomas
por: Han, Mingzhi, et al.
Publicado: (2022)

Establishment of an Endocytosis-Related Prognostic Signature for Patients With Low-Grade Glioma
por: Wang, Dawei, et al.
Publicado: (2021)

Siglec10—An immunosuppressor and negative predictor of survival prognosis in gliomas
por: Wang, Hesong, et al.
Publicado: (2022)

Prognosis and Immunotherapy Significances of a Cancer-Associated Fibroblasts-Related Gene Signature in Gliomas
por: Chen, Zhimin, et al.
Publicado: (2021)

Prognostic Value of a Stemness Index-Associated Signature in Primary Lower-Grade Glioma
por: Zhang, Mingwei, et al.
Publicado: (2020)

Prognostic Roles of Central Carbon Metabolism–Associated Genes in Patients With Low-Grade Glioma
por: Wang, Li, et al.
Publicado: (2019)

The Prognostic and Immunological Value of Guanylate-Binding Proteins in Lower-Grade Glioma: Potential Markers or Not?
por: Liu, Zhuang, et al.
Publicado: (2021)

Multi-Omics Analysis Based on Genomic Instability for Prognostic Prediction in Lower-Grade Glioma
por: Cao, Yudong, et al.
Publicado: (2022)

Roles of HMGBs in Prognosis and Immunotherapy: A Pan-Cancer Analysis
por: Lin, Tong, et al.
Publicado: (2021)

Classification related to immunogenic cell death predicts prognosis, immune microenvironment characteristics, and response to immunotherapy in lower-grade gliomas
por: Kuang, Yirui, et al.
Publicado: (2023)

Dissection of transcriptomic and epigenetic heterogeneity of grade 4 gliomas: implications for prognosis
por: Zeng, Chang, et al.
Publicado: (2023)

Molecular Subtypes Based on the Stemness Index Predict Prognosis in Glioma Patients
por: Tan, Jun, et al.
Publicado: (2021)

Immune-related gene risk score predicting the effect of immunotherapy and prognosis in bladder cancer patients
por: Zou, Yuantao, et al.
Publicado: (2022)

Prognostic Model and Nomogram Construction and Validation With an Autophagy-Related Gene Signature in Low-Grade Gliomas
por: Li, Xinrui, et al.
Publicado: (2022)

Cuproptosis-related gene signature stratifies lower-grade glioma patients and predicts immune characteristics
por: Zhang, Zihao, et al.
Publicado: (2022)

T cell exhaustion assessment algorism in tumor microenvironment predicted clinical outcomes and immunotherapy effects in glioma
por: Chen, Lie, et al.
Publicado: (2022)

The Role of Liquid Biopsy in the Diagnosis and Prognosis of WHO Grade 4 Astrocytoma
por: Halawa, Taher, et al.
Publicado: (2023)

Identification of immune related molecular subtypes and prognosis model for predicting prognosis, drug resistance in cervical squamous cell carcinoma
por: Hu, Dongzhi, et al.
Publicado: (2023)

Prediction of Prognosis and Immunotherapy of Osteosarcoma Based on Necroptosis-Related lncRNAs
por: Wang, Guowei, et al.
Publicado: (2022)

A necroptosis -related signature for predicting prognosis and immunotherapy in hepatocellular carcinoma
por: Fu, Xing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_38r53mt8ldfbn926dq7lsrgaof